B. Riley Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,981
| Closed | -$271K | – | 776 |
|
|
2022
Q1 | $271K | Buy |
4,981
+18
| +0.4% | +$979 | 0.02% | 481 |
|
|
2021
Q4 | $274K | Buy |
4,963
+20
| +0.4% | +$1.1K | 0.02% | 497 |
|
|
2021
Q3 | $236K | Sell |
4,943
-1,057
| -18% | -$50.5K | 0.02% | 517 |
|
|
2021
Q2 | $299K | Sell |
6,000
-2,065
| -26% | -$103K | 0.03% | 315 |
|
|
2021
Q1 | $360K | Sell |
8,065
-1,544
| -16% | -$68.9K | 0.04% | 268 |
|
|
2020
Q4 | $442K | Sell |
9,609
-4,214
| -30% | -$194K | 0.06% | 219 |
|
|
2020
Q3 | $650K | Buy |
13,823
+2,051
| +17% | +$96.4K | 0.08% | 195 |
|
|
2020
Q2 | $600K | Sell |
11,772
-2,124
| -15% | -$108K | 0.07% | 207 |
|
|
2020
Q1 | $658K | Buy |
13,896
+6,002
| +76% | +$284K | 0.07% | 238 |
|
|
2019
Q4 | $464K | Sell |
7,894
-1,800
| -19% | -$106K | 0.07% | 220 |
|
|
2019
Q3 | $517K | Sell |
9,694
-336
| -3% | -$17.9K | 0.09% | 200 |
|
|
2019
Q2 | $502 | Sell |
10,030
-1,304
| -12% | -$65 | 0.08% | 208 |
|
|
2019
Q1 | $592K | Buy |
11,334
+2,193
| +24% | +$115K | 0.1% | 191 |
|
|
2018
Q4 | $437K | Buy |
9,141
+1,008
| +12% | +$48.2K | 0.09% | 196 |
|
|
2018
Q3 | $408K | Buy |
+8,133
| New | +$408K | 0.1% | 172 |
|
|
2015
Q3 | – | Sell |
-2,910
| Closed | -$151K | – | 383 |
|
|
2015
Q2 | $151K | Sell |
2,910
-1,268
| -30% | -$65.8K | 0.12% | 217 |
|
|
2015
Q1 | $241K | Buy |
4,178
+20
| +0.5% | +$1.15K | 0.18% | 166 |
|
|
2014
Q4 | $222K | Buy |
4,158
+1,772
| +74% | +$94.6K | 0.18% | 142 |
|
|
2014
Q3 | $137K | Buy |
2,386
+572
| +32% | +$32.8K | 0.1% | 243 |
|
|
2014
Q2 | $121K | Buy |
1,814
+814
| +81% | +$54.3K | 0.08% | 315 |
|
|
2014
Q1 | $67K | Buy |
+1,000
| New | +$67K | 0.05% | 392 |
|